Literature DB >> 8396883

Poliovirus neutralising antibody in infants and cord blood.

M Yin-Murphy1, K L Tan, G N Lim, J H Quek, B Ishak, M C Phoon.   

Abstract

Singapore participated in the WHO EPI protocol for rapid assessment of serological response to three doses of standard oral poliovirus vaccine. The 100% seropositive finding of thirty infants below one year old is no proof of seroconversion rate to the Trivalent Oral Poliovirus Vaccine (TOPV) administered. Investigation of 100 cord blood samples showed that passively transferred maternal poliovirus neutralising antibody cannot be relied upon for protection of infants against poliomyelitis. This paper emphasises the importance of vaccine potency testing and serves as a timely reminder that although the last case of indigenous poliomyelitis was recorded in 1974, non Sabin-like (wild) polioviruses are being isolated from imported cases and foreigners hospitalised in Singapore, and unexpectedly, from the conjunctiva and pharynx of Singaporeans treated for conjunctivitis. It discusses the WHO (World Health Organization) Plan of Action for Eradication of Polio in the Western Pacific Region which includes Singapore.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396883

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  4 in total

1.  The changing seroepidemiology of enterovirus 71 infection among children and adolescents in Singapore.

Authors:  Li-Wei Ang; Meng-Chee Phoon; Yan Wu; Jeffery Cutter; Lyn James; Vincent T Chow
Journal:  BMC Infect Dis       Date:  2011-10-11       Impact factor: 3.090

2.  Seroepidemiology of Coxsackievirus A6, Coxsackievirus A16, and Enterovirus 71 Infections among Children and Adolescents in Singapore, 2008-2010.

Authors:  Li Wei Ang; Joanne Tay; Meng Chee Phoon; Jung Pu Hsu; Jeffery Cutter; Lyn James; Kee Tai Goh; Vincent Tak-Kwong Chow
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

3.  Monovalent type-1 oral poliovirus vaccine given at short intervals in Pakistan: a randomised controlled, four-arm, open-label, non-inferiority trial.

Authors:  Fatima Mir; Farheen Quadri; Ondrej Mach; Imran Ahmed; Zaid Bhatti; Asia Khan; Najeeb Ur Rehman; Elias Durry; Maha Salama; Steven M Oberste; William C Weldon; Roland W Sutter; Anita K M Zaidi
Journal:  Lancet Infect Dis       Date:  2015-06-17       Impact factor: 25.071

4.  Seroepidemiology of human enterovirus 71, Singapore.

Authors:  Eng-Eong Ooi; Meng-Chee Phoon; Baharudin Ishak; Soh-Ha Chan
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.